Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...
oncnursingnews5d
Topical Drug Combos May Be Beneficial for CIPN
Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...
Business Wire6d
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & Nasdaq: ARGX) today announced that China’s National Medical Products Administrat ...
KELOLAND News9d
Dynamic Spine & Neuropathy releases new book
Dr. Jeff Watson, with Dynamic Spine and Neuropathy in Sioux Falls, is a leading expert in the field of chiropractics. He recently released a groundbreaking new book titled “A Patient’s ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA
QUTENZA is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and ...
verywellhealth24d
Treating Your Depression and Nerve Pain With Cymbalta
This offers a great benefit to people infected with HIV, as both nerve pain, or peripheral neuropathy, and depression are common ailments. In addition, people with HIV have the burden of taking lots ...
American College of Cardiology26d
Peripheral Artery Disease: Implications For Health and Quality of Life
Peripheral artery disease (PAD) represents a significant global health burden, affecting millions of individuals worldwide, and its prevalence is significantly higher in individuals with known risk ...